Applied Materials Today, Journal Year: 2024, Volume and Issue: 40, P. 102381 - 102381
Published: Aug. 20, 2024
Language: Английский
Applied Materials Today, Journal Year: 2024, Volume and Issue: 40, P. 102381 - 102381
Published: Aug. 20, 2024
Language: Английский
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, Journal Year: 2024, Volume and Issue: 16(6)
Published: Nov. 1, 2024
ABSTRACT Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that often causes joint pain, swelling, and functional impairments. Drug therapy the main strategy used to alleviate symptoms of RA; however, drug may have several adverse effects, such as nausea, vomiting, abdominal diarrhea, gastric ulcers, intestinal bleeding, hypertension, hyperglycemia, infection, fatigue, indigestion. Moreover, long‐term excessive use drugs cause liver kidney dysfunction, well thrombocytopenia. Nanodrug delivery systems (NDDSs) can deliver therapeutics diseased sites with controlled release payload in an abnormal microenvironment, which helps reduce side effects therapeutics. Abnormalities decreased pH, increased expression matrix metalloproteinases (MMPs), concentrations reactive oxygen species (ROS), are associated progression RA but also provide opportunity achieve microenvironment‐responsive therapeutic at site. Microenvironment‐responsive NDDSs overcome abovementioned disadvantages therapy. Herein, we comprehensively review recent progress development for treatment, including pH‐, ROS‐, MMP‐, multiresponsive NDDSs. Furthermore, pathological microenvironment highlighted detail.
Language: Английский
Citations
2International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 282, P. 136831 - 136831
Published: Oct. 23, 2024
Language: Английский
Citations
1Applied Materials Today, Journal Year: 2024, Volume and Issue: 40, P. 102381 - 102381
Published: Aug. 20, 2024
Language: Английский
Citations
0